Warning about a low probability event: adverse liver reaction to GLP-1 drug

Most of the time they do. Thanks.

GLP-1 drugs almost never harm the liver. In my situation the doctor still thinks Lipitor is the main suspect. I had not come across Tudca or NAC until your note and looked them up afterward. I am not ready to say whether I would use them because I need more information first. I prefer to be careful with anything I add. If the bloodwork stays bad I will probably need a liver biopsy, which is outpatient but means two weeks off work.

I would not rule it out so fast. Reddit has posts from people who had to stop tirzepatide or retatrutide because of climbing liver enzymes. Keep us posted and take care.

That sounds plausible. A temporary rise under three times the upper limit is usually nothing to worry about. If retatrutide or tirzepatide were the issue I might have stayed on retatrutide without trouble. With my numbers so far above that I did not want to risk it without a doctor agreeing it was safe. I know my ALT was high enough to exclude me from any retatrutide trial.

I am not ruling out retatrutide or tirzepatide as the cause. I stopped retatrutide on the hepatologist's advice but kept tirzepatide on the same advice. I stressed how uncommon this is so others would not worry unnecessarily, yet I am concerned myself. A blood test is set for next Tuesday with results the following day. On tirzepatide alone I am gaining weight quickly and miss how easily retatrutide kept portions in check. I fear I may need months off these drugs and possibly a biopsy, though the doctor scheduled the next visit three months out and ran several tests for different liver problems, so major damage seems unlikely. Still, being off retatrutide is frustrating.

How frequently were the tests run after you switched to retatrutide?

You could try an ABAB pattern: one month off the GLP-1s with testing, one month back on with testing, and repeat. That single-subject approach can give clear answers. If tirzepatide is the problem you will know for sure. The same method works for Lipitor while keeping everything else steady. I am a scientist so I know these designs. Wishing you the best in figuring it out.

I have been running frequent tests for long covid, so I added liver and insulin checks almost every week since starting retatrutide.

Thanks for answering. After the switch when it first hit 50, how long until it returned to 42?

You mean the first time it reached 50? Roughly six weeks.

Yes, that first 50 and the climb and drop afterward. Really appreciate the details on your results after changing from tirzepatide to retatrutide.

Good news so far. Three main possibilities stand out: retatrutide alone, Lipitor alone, or an interaction between them. The on-off plan you described can test each one. If you wait another couple of weeks and see levels return to earlier values that would point strongly to retatrutide.

I will wait the two weeks and if numbers look normal I will reintroduce retatrutide. I still doubt retatrutide is responsible and lean toward Lipitor. I will not restart Lipitor because re-challenge in rare cases has led to fatalities. There is a decent chance the combination of Lipitor plus something else pushed the numbers so high.

You may be correct about Lipitor. The start date was not shown because it goes back twenty years, but the stop date three weeks ago should have been noted. Some people prefer pitavastatin because it affects the liver less and rarely causes muscle pain, though it is not as strong as atorvastatin or rosuvastatin.

The Lipitor start date was left out since I have taken it for twenty years. The stop date three weeks ago should have been included. People on Meso often mention pitavastatin as a statin with minimal liver impact and low muscle-pain risk, and it is reasonably potent though not as strong as atorvastatin or rosuvastatin for lowering cholesterol.

Processing fat and the toxins stored in it puts real stress on the liver. Rapid large-scale fat loss can overwork the organ, and the same goes for the kidneys. It makes sense to learn how to support both and to drop anything else that needs detoxifying.

What am I missing? Why would stopping a cholesterol-lowering drug not raise your lipids?

That is why I got divorced.

The size of the jump surprised me. I expected some increase, just like blood pressure would rise if I reduced my dose of BP medication.

Since starting GLP-1 drugs and cagri I have dropped two blood-pressure medicines and cut another by two-thirds. Pressure and labs have both improved a lot. So the tripled LDL came as a bit of a shock, though it is probably just a rebound from stopping Lipitor abruptly. The retatrutide I am titrating now may bring it back down through the glucagon effect.

It is still too soon to tell if retatrutide is the issue. Give it at least three more weeks. Since you are still on tirzepatide, an interaction between the two could be responsible. The only way to check is to stop tirzepatide, continue retatrutide by itself, and monitor for at least a month. Please keep updating us.

I did not follow that advice and stopped retatrutide again. After looking at LiverTox case reports I saw how unpredictable enzyme shifts can be. To judge whether changes are meaningful enough to implicate a drug, the RUCAM calculator is the standard tool researchers use. I chose not to keep taking retatrutide because I was worried about my liver and lacked a doctor willing to say it was safe. The hepatologist had previously thought retatrutide was unlikely to be the cause, but with more data I still decided to pause. I will stay off both retatrutide and Lipitor until enzymes are fully normal, though that may never happen.

I assume most of those tests lined up with doctor visits. Is it possible matching weight records exist that might show how weight loss factored in? I am not suggesting you made the wrong call stopping retatrutide or downplaying any liver risk. As someone also taking retatrutide I would like a fuller picture of possible downsides.

I do not have a firm answer, but I always use Tudca with any exogenous compound just for peace of mind.

Most visits were near doctor appointments, though a few were not. Hunting down the weights for the majority would take hours of searching records, so I will skip that. No published cases link retatrutide to liver toxicity. A handful of anecdotal social-media reports exist but none offer convincing proof. Since my last post I learned more.

I have no issue with the cautious route you are taking. Staying safe is reasonable. That said, your current plan will not clarify whether tirzepatide is contributing, especially via an interaction with retatrutide. The quoted statement notes the risk with long-term tirzepatide is unknown but probably very rare, yet it does not address a possible tirzepatide-retatrutide interaction. If enzymes return to normal, consider stopping tirzepatide and trying retatrutide alone after most of the tirzepatide has cleared. That would give a cleaner read on retatrutide's effect. You might gain a little weight in the meantime, but that can be managed later, possibly even with retatrutide by itself. Keep tracking everything carefully.

I do not smoke or drink alcohol.

Thanks for all the information. I may have missed it, but could you share the tirzepatide and retatrutide doses you were using? Did the enzyme levels track with changes in those doses?

Enzymes have generally run higher since I began retatrutide, but I saw no clear link to dose. Rather than listing doses that changed with weekly frequency, I can share the calculated body levels of each drug on the test dates. Drug-induced liver injury is often idiosyncratic, meaning it can occur regardless of dose or how long the drug has been taken.